The appropriate alternative depends on your individual clinical situation and treatment goals
However, pea protein powders can be relatively expensive and often have a mildly earthy flavor, which may not appeal to everyone
Novo Nordisk built an entire phase 3 program, branded CagriSema, around the idea of bolting an amylin analog onto a GLP-1 agonist
The 24.2% average weight loss with Retatrutide means the typical participant ended up more than one-fifth lighter than when they started
Treatment discontinuation due to gastrointestinal events occurred in a minority of patients, and overall, serious adverse events were similar to those with the placebo
Mara Jos Soler is the CKJ Editor-in-Chief and reports honorarium for conferences, consulting fees and advisory boards from AstraZeneca, Novo-Nordsik, Esteve, Vifor, Travere Therapeutics, Bayer, Mundipharma, Ingelheim Lilly, Jansen, ICU Medical and Boehringer